𝔖 Bobbio Scriptorium
✦   LIBER   ✦

(2) A double-blind placebo-controlled trial of topical hexyl nicotinate lotion in primary Raynaud's phenomenon

✍ Scribed by C.B. Bunker; F. Cooper; Pauline M. Dowd

Book ID
108661442
Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
124 KB
Volume
121
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Danyu Lin; Dr Mary F. πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 792 KB

One hundred fifty-one patients with primary biliary cirrhosis (PBC) grouped into four strata based on entry serum bilirubin (<2 mg/dL vs. 2 mg/dL or greater) and liver histology (stages I, 1 1 vs. stages 111, IV-Ludwig criteria) were randomized within each stratum to ursodiol or placebo given in a s

Prevention of vascular damage in sclerod
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril
✍ A. E. Gliddon; C. J. DorΓ©; C. M. Black; N. McHugh; R. Moots; C. P. Denton; A. He πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the efficacy and tolerability of prolonged administration of quinapril, a long‐acting angiotensin‐converting enzyme inhibitor, in the management of the peripheral vascular manifestations of limited cutaneous systemic sclerosis (lcSSc) and in the prevention of t